Enabling Cellular Delivery of Therapeutics
Targeted Oncology Solutions
Past and Present
More than 100 Issued Patents
Disruptive Platform Technology
More than 100 Issued Patents
Decades of Research
Disruptive Platform Technology
More than 100 Issued Patents
Disruptive Platform Technology
Disruptive Platform Technology
Disruptive Platform Technology
LEADERSHIP
Gary Strange, Chairman of the Board and Founder
Franck Carlier Chief Executive Officer
Franck Carlier Chief Executive Officer
Gary has 30+ years' experience working with businesses from start up to exit. He is a visionary that brought LifePulse from concept to reality in five years.
Franck Carlier Chief Executive Officer
Franck Carlier Chief Executive Officer
Franck Carlier Chief Executive Officer
Former Global CIO at Eurofins & Essilor
Led 3,500+ employees, managing $400M+ budgets.
CEO of VisionWeb, scaled $28M business, drove 20% YoY growth.
Dr Loree Heller Chief Science Officer
Franck Carlier Chief Executive Officer
Dr Loree Heller Chief Science Officer
Over 40 years experience in the sciences. PhD in molecular biology. Research scientist emeritus, University of South Florida.
Gerald Sokol, MD Chief Medical Officer
Franck Carlier Chief Executive Officer
Dr Loree Heller Chief Science Officer
Decades of experience in direct patient care with extensive experience leading clinical trials. Dr Sokol has multiple boardings and is affiliated with Cleveland Clinic.
SCIENCETIFIC AND REGULATORY ADVISORY BOARD
Dr. Richard Heller, CSO
Chelsea Tripp, DVM, ACVIM, Oncology
Dr. Mark Jaroszeski, VP Research
Dr Heller is the preeminent scientist worldwide for electroporation based technologies and Fellow of the National Inventors Hall of Fame
Dr. Mark Jaroszeski, VP Research
Chelsea Tripp, DVM, ACVIM, Oncology
Dr. Mark Jaroszeski, VP Research
Dr Jaroszeski has worked side by side with Dr Heller for more than three decades and is also a Fellow of the National Inventors Hall of Fame
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
Dr Tripp is the most recognized expert for this type of technology in veterinary medicine and is a sought-after speaker and key opinion leader
Alexander Fleming, MD
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
A physician by training, Dr Fleming is the founder of Kinexum, a highly respected FDA translational guidance firm based in Washington, DC
About Us
Our History
A combined more than 100 years of collective research produced a series of patents we acquired in 2020 before Pulsed Electrical Fields became one of most important technologies in Biotech.
Our Patents
LifePulse is the beneficiary of more than $35M and decades of R&D that are undiluted investment in the company. This has allowed us to build a fortress of patents surrounding every aspect of our technology.
Our Mission
We are dedicated to make this life changing technology available to the US first, and then the world. The worldwide unmet need is staggering for this disruptive technology. Beginning with pancreatic tumor trials in 2026, we boldly go to change outcomes and quality of life for the terminally ill.
Animal Health Division
LifePulse Bioscience
Since March, 2022 hundreds of dogs, cats and horses have been successfully treated for dozens of indications. Our veterinary devices are now in clinical use throughout the US and soon abroad. For more information visit our Animal Health website (lifepulsebio.com)
Human Health
LifePulse ® Intellipulse ® technology is a quantum leap forward in targeted therapy. A platform for delivery of therapeutics whose efficacy is improved by cellular delivery, Intellipulse ® brings the first major advancement to Pulsed Electrical Fields in a generation.
Pharmaceutical Division
Innovation in pharmaceuticals is a LifePulse ® prerogative. Watch for new information in the upcoming pipeline. We are developing drugs specifically for delivery with Intellipulse ®. A recently filed PCT patent for a very large protein only deliverable with Intellipulse ® promises to be a watermark discovery.
Join Us
Research Division
Research of therapeutics using cellular delivery is going to change outcomes for millions of patients. Therapeutic delivery at the cellular level in this manner is a game changer in both veterinary and human medicine.
US Engineered and Manufactured Platform Technology
Contact Us
Located in the Tampa Bay Medical Park
For clinical trial information contact us at
LifePulse Corporation